Tablet
VANFLYTA TABLETS 26.5MG
Summary
VANFLYTA TABLETS 26.5MG — Tablet containing quizartinib (as dihydrochloride). Hong Kong Registration No. HK-68662. Certificate Holder: DAIICHI SANKYO HONG KONG LIMITED. Date of Registration: 25 Apr, 2025.
Product NameVANFLYTA TABLETS 26.5MG
Registration No.HK-68662
Certificate HolderDAIICHI SANKYO HONG KONG LIMITED
Holder AddressSUITES 3207-11, 32/F, TOWER ONE, TIMES SQUARE, 1, MATHESON STREET, CAUSEWAY BAY, HONG KONG
Ingredientsquizartinib (as dihydrochloride)
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration25 Apr, 2025
ATC codesL01EX11
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。